Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Oncology Market

Veterinary Oncology Market Share

Report ID: GMI8527
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Veterinary Oncology Market Share

The veterinary oncology industry is characterized by the presence of several key players offering innovative solutions. The strategic partnerships, mergers, and acquisitions are common strategies employed by players to expand their market presence, enhance their product portfolios, and gain a competitive advantage.

Veterinary Oncology Market Companies

Prominent players operating in the veterinary oncology industry include:

AB Science
Accuray Incorporated
Boehringer Ingelheim International GmbH
Elanco
Karyopharm Therapeutics, Inc
NIPPON ZENYAKU KOGYO CO., LTD
PetCure Oncology
Regeneus Ltd
Varian Medical Systems, Inc
Virbac Corporation
Zoetis Services LLC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global veterinary oncology industry size was USD 923.5 million in 2023 and is predicted to reach USD 1.7 billion by 2032, due to increasing pet ownership and awareness along with significant focus on early detection and diagnosis of cancer in animals.

The cancer diagnostics & treatment segment recorded 56.2% of the market share in 2023, driven by the strong potential for localized treatment.

North America veterinary oncology market size was USD 400.8 million in 2023 and is anticipated to grow at 6.9% CAGR between 2024 – 2032, led by the escalating governmental support for pet oncology treatment and the growing emphasis on pet health.

Some of the prominent veterinary oncology firms include AB Science, Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco, NIPPON ZENYAKU KOGYO CO., LTD, PetCure Oncology, Regeneus Ltd, Varian Medical Systems, Inc, and Virbac Corporation.